Biologic Excipient Market Forecasted to Expand from USD 1.5 Billion in 2024

The biologic excipients market has become a vital component of the pharmaceutical and biotechnology industries, playing a crucial role in the formulation of biologic drugs. These excipients are inactive substances used alongside active pharmaceutical ingredients (APIs) to ensure stability, bioavailability, and effective delivery of the drug. As the demand for biologics such as monoclonal antibodies, …

Behavioral Health Market Projected to Grow at 3% CAGR Through 2034

The global behavioral health market is estimated at USD 127 billion in 2024 and is anticipated to generate revenues of USD 175.7 billion by 2034. The industry is forecast to rise at a CAGR of 3% in the forecast period. The behavioural health market encompasses a broad range of services and treatments designed to address …

Pulmonary Arterial Hypertension Treatment Market Growth Forecast at 2.3% CAGR Until 2035

The pulmonary arterial hypertension treatment market has witnessed a significant transformation in recent years, driven by advancements in medical research and increasing awareness about rare cardiovascular diseases. Pulmonary arterial hypertension (PAH) is a progressive condition characterized by elevated blood pressure in the arteries that supply the lungs, which can lead to heart failure if left …

Muscle Stimulation Devices Market Set for Steady Growth Through 2035

The Muscle Stimulation Devices Market is valued at USD 781.9 million USA dollars in 2025. The market to grow through CAGR 3.9% over the forecast years and is expected to reach USD 1,146.6 million by 2035. The muscle stimulation devices market is witnessing consistent growth due to the increasing demand for non-invasive therapies that promote …

Whole Genome Amplification Market Projected to Grow from USD 2.9 Million in 2024 to Over USD 6.5 Million by 2034

The whole genome amplification market is anticipated to reach over USD 6.5 million by 2034, with sales projected to reach USD 2.9 million in 2024. The WGA industry is envisioned to register an 8.1% CAGR between 2024 and 2034, highlighting its sustained demand and potential impact on various research fields. The whole genome amplification market …

Orthokeratology Market to Reach USD 659.1 Million by 2034 at 4.8% CAGR

The orthokeratology market is experiencing substantial growth as more individuals seek non-surgical alternatives to correct refractive errors. Orthokeratology, commonly referred to as Ortho-K, involves the use of specially designed gas-permeable contact lenses that reshape the cornea overnight. This technique provides clear vision during the day without the need for glasses or contact lenses. With growing …

Laparoscopic Device Market to Surpass USD 20.5 Billion by 2034, Growing at 4.2% CAGR

The need for laparoscopic devices is predicted to rise at a sluggish CAGR of 4.2% through 2034. The industry is projected to surpass USD 20.5 billion by 2034. The surge in the prevalence of obesity across all age groups is raising the market growth. The laparoscopic devices market has gained significant attention in recent years, …

Cellulite Treatment Market to Surge to USD 7.37 Billion by 2034, Growing at 7.2% CAGR

The global cellulite treatment market is expected to be valued at USD 3.67 billion in 2024 and is projected to grow at a CAGR of 7.2% during the forecast period from 2024 to 2034, eventually exceeding USD 7.37 billion by 2034. The cellulite treatment market is gaining significant traction as awareness about skin aesthetics and …

Rare Neurological Disease Treatment Market Forecast USD 19.95 Billion in 2025 to USD 40.67 Billion by 2035

The global sales of rare neurological disease treatment is estimated to be worth USD 19.95 billion in 2025 and anticipated to reach a value of USD 40.67 billion by 2035. Sales are projected to rise at a CAGR of 7.4% over the forecast period between 2025 and 2035. The revenue generated by rare neurological disease …

Rare Inflammatory Disease Treatment Market to Reach USD 17.33 Billion by 2028 at 4.6% CAGR

The Rare Inflammatory Disease Treatment Market has garnered a market value of USD 12,664 Million in 2021, anticipated to register a positive CAGR of 4.6% in the forecast period 2022 to 2028 and reach a value of USD 17,335.8 Million. The rare inflammatory disease treatment market has been garnering significant attention within the healthcare sector …